Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Gene Ther ; 20(9): 949-57, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23615186

ABSTRACT

Transplantation of epithelia derived from keratinocyte stem cells transduced by retroviral vectors is a potential therapy for epidermolysis bullosa (EB), a family of inherited skin adhesion defects. The biosafety characteristics of retroviral vectors in keratinocytes are, however, poorly defined. We developed self-inactivating (SIN) vectors derived from the Moloney murine leukemia (MLV) and the human immunodeficiency (HIV) viruses expressing therapeutic levels of LAMB3, a transgene defective in junctional EB, and tested their integration profile in human primary keratinocytes. The SIN-HIV vector showed the expected preference for transcribed genes while the SIN-MLV vector integrated preferentially in regulatory elements, but showed a significantly lower tendency to target cell growth-related genes, transcription start sites and epigenetically defined promoters compared with a wild-type MLV vector in an epithelial cell context. A quantitative gene expression assay in individual keratinocyte clones showed that MLV-derived vectors deregulate expression of targeted genes at a lower frequency than in hematopoietic cells, and that the SIN-MLV design has the lowest activity compared to both MLV and SIN-HIV vectors. This study indicates that SIN-MLV vectors may have a better safety profile in keratinocyte than in hematopoietic cells, and be a reasonable alternative to lentiviral vectors for gene therapy of inherited skin disorders.


Subject(s)
Cell Adhesion Molecules/genetics , Epidermolysis Bullosa/genetics , Epidermolysis Bullosa/therapy , Genetic Vectors , Keratinocytes/metabolism , Moloney murine leukemia virus/genetics , Virus Integration , Animals , Cell Adhesion Molecules/metabolism , Epidermolysis Bullosa/metabolism , Gene Expression Regulation , Genetic Therapy , HIV-1/genetics , HeLa Cells , Humans , Mice , Moloney murine leukemia virus/physiology , Promoter Regions, Genetic , Swiss 3T3 Cells , Transduction, Genetic , Transgenes , Virus Inactivation , Kalinin
2.
J Virol ; 75(22): 11205-17, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11602760

ABSTRACT

The hepatitis C virus (HCV) envelope proteins, E1 and E2, form noncovalent heterodimers and are leading candidate antigens for a vaccine against HCV. Studies in mammalian cell expression systems have focused primarily on E2 and its folding, whereas knowledge of E1 folding remains fragmentary. We used a cell-free in vitro translation system to study E1 folding and asked whether the flanking proteins, Core and E2, influence this process. We translated the polyprotein precursor, in which the Core is N-terminal to E1, and E2 is C-terminal, and found that when the core protein was present, oxidation of E1 was a slow, E2-independent process. The half-time for E1 oxidation was about 5 h in the presence or absence of E2. In contrast with previous reports, analysis of three constructs of different lengths revealed that the E2 glycoprotein undergoes slow oxidation as well. Unfolded or partially folded E1 bound to the endoplasmic reticulum chaperones calnexin and (with lower efficiency) calreticulin, whereas no binding to BiP/GRP78 or GRP94 could be detected. Release from calnexin and calreticulin was used to assess formation of mature E1. When E1 was expressed in the absence of Core and E2, its oxidation was impaired. We conclude that E1 folding is a process that is affected not only by E2, as previously shown, but also by the Core. The folding of viral proteins can thus depend on complex interactions between neighboring proteins within the polyprotein precursor.


Subject(s)
Protein Folding , Viral Envelope Proteins/chemistry , Cell-Free System , Endoplasmic Reticulum/virology , Oxidation-Reduction
3.
J Mol Biol ; 302(3): 539-52, 2000 Sep 22.
Article in English | MEDLINE | ID: mdl-10986117

ABSTRACT

Transcription of major histocompatibility complex (MHC) class II genes depends upon the trimeric complexes RFX and NF-Y binding to the conserved X-Y promoter elements. We produced and purified the RFX subunits from Escherichia coli, reconstituted DNA-binding to the mouse Ea X box and dissected the interactions with NF-Y. RFX and NF-Y do not interact in solution, but make cooperative interactions in EMSA: a minimal NF-Y, composed of the evolutionary conserved domains, is sufficient and the RFXAP N-terminal half is expendable. Altering the X-Y distance abolishes cooperativity, indicating that DNA imposes severe spatial constraints. When tested on a highly positioned nucleosome, RFX binds DNA well and NF-Y does not increase its affinity further. Transfections of NF-Y subunits, but not RFX, in class II negative cells improves basal transcription and coexpression of the two activators has a synergistic effect, while modestly increasing CIITA-mediated activation. These results show that interactions between the two trimers on DNA are key to MHC class II expression.


Subject(s)
DNA-Binding Proteins/metabolism , Genes, MHC Class II/genetics , Nuclear Proteins , Promoter Regions, Genetic/genetics , Transcription Factors/metabolism , Animals , Binding Sites , CCAAT-Enhancer-Binding Proteins , Cell Line , Conserved Sequence/genetics , DNA/chemistry , DNA/genetics , DNA/metabolism , DNA-Binding Proteins/genetics , Kinetics , Mice , Mutation , Nucleic Acid Conformation , Nucleosomes/chemistry , Nucleosomes/genetics , Nucleosomes/metabolism , Precipitin Tests , Protein Binding , Recombinant Proteins/metabolism , Regulatory Factor X Transcription Factors , Response Elements/genetics , Thermodynamics , Trans-Activators/genetics , Trans-Activators/metabolism , Transcription Factors/genetics , Transcription, Genetic/genetics , Transcriptional Activation/genetics , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL
...